Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial

Asger Sand Paludan-Müller1, Michelle C Ogden1, Mikkel Marquardsen1

  • 1Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark.

BMJ Open
|November 13, 2019
PubMed
Abstract

Insights

Few new clinical trials adequately consider previous evidence, potentially exposing participants to suboptimal treatments. Ethical approval processes should mandate systematic literature searches to ensure robust trial justification and reduce research waste.

Area of Science:

  • Clinical trial methodology
  • Research ethics
  • Evidence-based medicine

Background:

  • New clinical trials are essential for advancing medical knowledge.
  • Ensuring new trials build upon existing evidence is crucial for efficiency and participant safety.
  • The extent to which prior research informs new trial design is not well-documented.

Purpose of the Study:

  • To assess the consideration of previous trial evidence in new randomized trial protocols.
  • To evaluate the justification and evidence base for newly proposed clinical trials.

Main Methods:

  • A cohort study of randomized trial protocols approved by Danish ethics committees (January 2012 - March 2013).
  • Protocols were screened for explicit mention of literature searches and evidence of systematic searches.
  • Simple search strategies were used to identify potentially relevant cited or uncited trials.

Main Results:

  • Only 3% of 67 protocols explicitly stated conducting a literature search; only 1% allowed replication.
  • 16% of protocols had insufficient information to judge ethical justification due to comparator or rationale issues.
  • Relevant prior trials that could have supported justification were identified for 12% of protocols.

Conclusions:

  • A substantial minority of new trials may lack a sufficient evidence base.
  • The limited use of literature searches hinders the assessment of prior evidence consideration.
  • Mandatory systematic literature searches for ethical approval are recommended to prevent research waste and protect participants.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
362
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
817
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
140
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
185